Clinical Trial Update: Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial assessing safety and immune response of two influenza vaccines in HIV-infected children and adolescents (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Influenza | Phase 1, Phase 2 | Status: COMPLETED